Melatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathy

Basit Öğe Kaydı
dc.authoridŞahin, Erkan Melih/0000-0003-1520-8464
dc.contributor.authorOcak, Ozgul
dc.contributor.authorSılan, Fatma
dc.contributor.authorŞahin, Erkan Melih
dc.date.accessioned2025-01-27T20:49:44Z
dc.date.available2025-01-27T20:49:44Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractAims Oxidative stress plays an important role in the pathogenesis of diabetic peripheral neuropathy (DPN). Melatonin is one of the most powerful endogenous antioxidants and has anti-inflammatory properties. We investigated how the gene polymorphism of melatonin differs in patients with DPN compared to an healthy control group. Materials and Methods A total of 54 diabetic peripheral neuropathy patients who applied to the Neurology outpatient clinic between 2020 and 2021, and 53 healthy controls comparable with the patient group in terms of age and gender were included in the study. Electromyography was performed and the melatonin gene polymorphism was analysed using the pyrosequencing method. Results Melatonin gene variants rs2119882, rs13140012, and rs10830963 were analysed in patients and controls. The rs2119882 (G allele) has a protective role, and rs13140012 polymorphism has a related 5-fold higher risk of DPN in the recessive model. Conclusions Melatonin gene polymorphisms have been shown to be associated with DPN. This is the first and only study investigating the relationship between melatonin gene polymorphisms and DPN. Ethnicity is very important in genetic studies, and it will give us more information on the role of melatonin gene variants in larger study groups of diabetic patients of other ethnic origin.
dc.identifier.doi10.1002/dmrr.3573
dc.identifier.issn1520-7552
dc.identifier.issn1520-7560
dc.identifier.issue8
dc.identifier.pmid36018079
dc.identifier.scopus2-s2.0-85137379393
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/dmrr.3573
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25298
dc.identifier.volume38
dc.identifier.wosWOS:000849570800001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofDiabetes-Metabolism Research and Reviews
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectdiabetic peripheral neuropathy
dc.subjectgenetics
dc.subjectinflammation
dc.subjectmelatonin gene polymorphism
dc.titleMelatonin receptor gene polymorphisms as a risk factor in patients with diabetic peripheral neuropathy
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu